当前位置: 首页 > 期刊 > 《中国实用医药》 > 2011年第2期 > 正文
编号:11986770
低分子肝素治疗急性脑梗死的临床研究(2)
http://www.100md.com 2011年1月15日 李凤君 孙广斌
第1页

    参见附件(2831KB,2页)。

     总之,低分子肝素治疗急性脑梗死有效且较为安全。

    参考文献

    [1] Ishikawa Y, Hirayama T, Nakamura Y, et al. Incidental cerebral aneurysms in acute stroke patients:comparison of asymptomatic healthy controls.J Neurol Sci,2010,298(1-2):42-45.

    [2] Kramer AH, Mikolaenko I, Deis N, et al. Intraventricular hemorrhage volume predicts poor outcomes but not delayed ischemic neurological deficits among patients with ruptured cerebral aneurysms.Neurosurgery,2010,67(4):1044-1052.

    [3] Dobesh P. The importance of appropriate prophylaxis for the prevention of venous thromboembolism in at-risk medical patients.Int J Clin Pract,2010,64(11):1554-1562.

    [4] Iqbal Z, Cohen M.Emerging antithrombotic agents:what does the intensivist need to know Curr Opin Crit Care,2010,16(5):419-425.

    [5] Cnossen MH, van Ommen CH, Appel IM. Etiology and treatment of perinatal stroke; a role for prothrombotic coagulation factors Semin Fetal Neonatal Med,2009,14(5):311-317.

    [6] Quartermain D, Li YS, Jonas S. Acute enoxaparin treatment widens the therapeutic window for tPA in a mouse model of embolic stroke.Neurol Res,2007,29(5):469-475.

    共2页

您现在查看是摘要介绍页,详见PDF附件(2831KB,2页)